Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Sterne JAC, Abubakar I, Smith PG, Fine PEM, Vynnycky E, Watson JM, Elliman D, Lipman M, Rodrigues LC.

Int J Epidemiol. 2018 Feb 1;47(1):193-201. doi: 10.1093/ije/dyx141.

2.

Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.

Mangtani P, Nguipdop-Djomo P, Keogh RH, Trinder L, Smith PG, Fine PE, Sterne J, Abubakar I, Vynnycky E, Watson J, Elliman D, Lipman M, Rodrigues LC.

Health Technol Assess. 2017 Jul;21(39):1-54. doi: 10.3310/hta21390.

3.
4.

Risk factors for Mycobacterium tuberculosis infection in 2-4 year olds in a rural HIV-prevalent setting.

Khan PY, Glynn JR, Fielding KL, Mzembe T, Mulawa D, Chiumya R, Fine PE, Koole O, Kranzer K, Crampin AC.

Int J Tuberc Lung Dis. 2016 Mar;20(3):342-9. doi: 10.5588/ijtld.15.0672.

5.

The decline of leprosy in the Republic of Korea; patterns and trends 1977-2013.

Lee J, Kim JP, Nishikiori N, Fine PE.

Lepr Rev. 2015 Dec;86(4):316-27.

PMID:
26964427
6.

Impact of foot-and-mouth disease on milk production on a large-scale dairy farm in Kenya.

Lyons NA, Alexander N, Stärk KDC, Dulu TD, Sumption KJ, James AD, Rushton J, Fine PEM.

Prev Vet Med. 2015 Jun 15;120(2):177-186. doi: 10.1016/j.prevetmed.2015.04.004. Epub 2015 Apr 16.

PMID:
25912977
7.

Impact of foot-and-mouth disease on mastitis and culling on a large-scale dairy farm in Kenya.

Lyons NA, Alexander N, Stӓrk KD, Dulu TD, Rushton J, Fine PE.

Vet Res. 2015 Apr 16;46:41. doi: 10.1186/s13567-015-0173-4.

8.

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.

Guerra-Assunção JA, Crampin AC, Houben RM, Mzembe T, Mallard K, Coll F, Khan P, Banda L, Chiwaya A, Pereira RP, McNerney R, Fine PE, Parkhill J, Clark TG, Glynn JR.

Elife. 2015 Mar 3;4. doi: 10.7554/eLife.05166.

9.

Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.

Lyons NA, Stärk KD, van Maanen C, Thomas SL, Chepkwony EC, Sangula AK, Dulu TD, Fine PE.

Acta Trop. 2015 Mar;143:103-11. doi: 10.1016/j.actatropica.2014.09.010. Epub 2014 Oct 24.

PMID:
25447264
10.

Reply to Kernodle and von Reyn.

Mangtani P, Rodrigues LC, Sterne JA, Abubakar I, Fine PE.

Clin Infect Dis. 2014 Aug 15;59(4):608-9. doi: 10.1093/cid/ciu330. Epub 2014 May 6. No abstract available.

PMID:
24803378
11.

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.

Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, Sterne JA.

Clin Infect Dis. 2014 Feb;58(4):470-80. doi: 10.1093/cid/cit790. Epub 2013 Dec 13. Review.

12.

Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.

Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, Fine PE, Smith PG, Lipman M, Elliman D, Watson JM, Drumright LN, Whiting PF, Vynnycky E, Rodrigues LC.

Health Technol Assess. 2013 Sep;17(37):1-372, v-vi. doi: 10.3310/hta17370. Review.

13.

Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi.

Mboma SM, Houben RM, Glynn JR, Sichali L, Drobniewski F, Mpunga J, Fine PE, French N, Crampin AC.

PLoS One. 2013;8(3):e58192. doi: 10.1371/journal.pone.0058192. Epub 2013 Mar 6.

14.

A major event for new tuberculosis vaccines.

Dye C, Fine PE.

Lancet. 2013 Mar 23;381(9871):972-4. No abstract available.

15.

Patterns and trends of leprosy in Mexico: 1989-2009.

Larrea MR, Carreño MC, Fine PE.

Lepr Rev. 2012 Jun;83(2):184-94.

PMID:
22997694
16.

Profile: the Karonga Health and Demographic Surveillance System.

Crampin AC, Dube A, Mboma S, Price A, Chihana M, Jahn A, Baschieri A, Molesworth A, Mwaiyeghele E, Branson K, Floyd S, McGrath N, Fine PE, French N, Glynn JR, Zaba B.

Int J Epidemiol. 2012 Jun;41(3):676-85. doi: 10.1093/ije/dys088. Epub 2012 Jun 22.

17.

BCG: myths, realities, and the need for alternative vaccine strategies.

McShane H, Jacobs WR, Fine PE, Reed SG, McMurray DN, Behr M, Williams A, Orme IM.

Tuberculosis (Edinb). 2012 May;92(3):283-8. doi: 10.1016/j.tube.2011.12.003. Epub 2012 Feb 18. No abstract available.

18.

Non-specific effects of BCG?

Fine PE, Smith PG, Evans SJ.

J Infect Dis. 2012 Feb 1;205(3):515; author reply 517-8. doi: 10.1093/infdis/jir760. Epub 2011 Dec 6. No abstract available.

PMID:
22147789
19.

BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi.

Lalor MK, Floyd S, Gorak-Stolinska P, Ben-Smith A, Weir RE, Smith SG, Newport MJ, Blitz R, Mvula H, Branson K, McGrath N, Crampin AC, Fine PE, Dockrell HM.

J Infect Dis. 2011 Oct 1;204(7):1075-85. doi: 10.1093/infdis/jir515.

20.

Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC.

BMC Med. 2011 Apr 12;9:36. doi: 10.1186/1741-7015-9-36. Review.

21.

Married to M. tuberculosis: risk of infection and disease in spouses of smear-positive tuberculosis patients.

Crampin A, Kasimba S, Mwaungulu NJ, Dacombe R, Floyd S, Glynn JR, Fine PE.

Trop Med Int Health. 2011 Jul;16(7):811-8. doi: 10.1111/j.1365-3156.2011.02763.x. Epub 2011 Mar 29.

22.

BCG vaccination: a role for vitamin D?

Lalor MK, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM.

PLoS One. 2011 Jan 31;6(1):e16709. doi: 10.1371/journal.pone.0016709.

23.

Measles eradication: past is prologue.

Heymann DL, Fine PE, Griffiths UK, Hall AJ, Mounier-Jack S.

Lancet. 2010 Nov 20;376(9754):1719-20. doi: 10.1016/S0140-6736(10)61934-4. No abstract available.

PMID:
21093636
24.

What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.

McGrath N, Glynn JR, Saul J, Kranzer K, Jahn A, Mwaungulu F, Ngwira MH, Mvula H, Munthali F, Mwinuka V, Mwaungulu L, Fine PE, Crampin AC.

BMC Public Health. 2010 Oct 12;10:601. doi: 10.1186/1471-2458-10-601.

25.

Declining child mortality in northern Malawi despite high rates of infection with HIV.

Jahn A, Floyd S, Crampin AC, Mvula H, Mwinuka V, Mwaiyeghele E, McGrath N, Zaba B, Fine PE, Glynn JR.

Bull World Health Organ. 2010 Oct 1;88(10):746-53. doi: 10.2471/BLT.09.075085. Epub 2010 May 10.

26.

'Environmental' sources of Mycobacterium leprae: issues and evidence.

Truman R, Fine PE.

Lepr Rev. 2010 Jun;81(2):89-95. No abstract available.

PMID:
20825112
27.

Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi.

Glynn JR, Alghamdi S, Mallard K, McNerney R, Ndlovu R, Munthali L, Houben RM, Fine PE, French N, Crampin AC.

PLoS One. 2010 Aug 17;5(8):e12259. doi: 10.1371/journal.pone.0012259.

28.

Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.

Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, Sirugo G, Sisay-Joof F, Enimil A, Chinbuah MA, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Ngwira B, Teo YY, Small K, Rockett K, Kwiatkowski D, Fine PE, Hill PC, Newport M, Lienhardt C, Adegbola RA, Corrah T, Ziegler A; African TB Genetics Consortium; Wellcome Trust Case Control Consortium, Morris AP, Meyer CG, Horstmann RD, Hill AVS.

Nat Genet. 2010 Sep;42(9):739-741. doi: 10.1038/ng.639. Epub 2010 Aug 8. Erratum in: Nat Genet. 2011 Oct;43(10):1040.

29.

Leprosy and the adaptation of human toll-like receptor 1.

Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, Khor CC, Rautanen A, Chapman SJ, Mills TC, Srivastava A, Rudko A, Freidin MB, Puzyrev VP, Ali S, Aggarwal S, Chopra R, Reddy BS, Garg VK, Roy S, Meisner S, Hazra SK, Saha B, Floyd S, Keating BJ, Kim C, Fairfax BP, Knight JC, Hill PC, Adegbola RA, Hakonarson H, Fine PE, Pitchappan RM, Bamezai RN, Hill AV, Vannberg FO.

PLoS Pathog. 2010 Jul 1;6:e1000979. doi: 10.1371/journal.ppat.1000979.

30.

Child mortality in rural Malawi: HIV closes the survival gap between the socio-economic strata.

Jahn A, Floyd S, McGrath N, Crampin AC, Kachiwanda L, Mwinuka V, Zaba B, Fine PE, Glynn JR.

PLoS One. 2010 Jun 28;5(6):e11320. doi: 10.1371/journal.pone.0011320.

31.

Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection.

Houben RM, Glynn JR, Mallard K, Sichali L, Malema S, Fine PE, French N, Crampin AC.

Int J Tuberc Lung Dis. 2010 Jul;14(7):909-15.

32.

CISH and susceptibility to infectious diseases.

Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, Vukcevic D, Rautanen A, Mills TC, Chang KC, Kam KM, Crampin AC, Ngwira B, Leung CC, Tam CM, Chan CY, Sung JJ, Yew WW, Toh KY, Tay SK, Kwiatkowski D, Lienhardt C, Hien TT, Day NP, Peshu N, Marsh K, Maitland K, Scott JA, Williams TN, Berkley JA, Floyd S, Tang NL, Fine PE, Goh DL, Hill AV.

N Engl J Med. 2010 Jun 3;362(22):2092-101. doi: 10.1056/NEJMoa0905606. Epub 2010 May 19.

33.

The decline of leprosy in Japan: patterns and trends 1964-2008.

Koba A, Ishii N, Mori S, Fine PE.

Lepr Rev. 2009 Dec;80(4):432-40.

PMID:
20306642
34.

Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi.

Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, Fine PE, Glynn JR.

AIDS. 2010 Jan 28;24(3):417-26. doi: 10.1097/QAD.0b013e32832f51cf.

35.

Complex cytokine profiles induced by BCG vaccination in UK infants.

Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM.

Vaccine. 2010 Feb 10;28(6):1635-41. doi: 10.1016/j.vaccine.2009.11.004. Epub 2009 Nov 24.

36.

Landscape analysis of interactions between nutrition and vaccine responses in children.

Savy M, Edmond K, Fine PE, Hall A, Hennig BJ, Moore SE, Mulholland K, Schaible U, Prentice AM.

J Nutr. 2009 Nov;139(11):2154S-218S. doi: 10.3945/jn.109.105312. Epub 2009 Sep 30. Review.

PMID:
19793845
37.

Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants.

Hesseling AC, Johnson LF, Jaspan H, Cotton MF, Whitelaw A, Schaaf HS, Fine PE, Eley BS, Marais BJ, Nuttall J, Beyers N, Godfrey-Faussett P.

Bull World Health Organ. 2009 Jul;87(7):505-11.

38.

Polio: measuring the protection that matters most.

Fine PE.

J Infect Dis. 2009 Sep 1;200(5):673-5. doi: 10.1086/605331. No abstract available.

PMID:
19624277
39.

Epidemiological studies of the 'non-specific effects' of vaccines: I--data collection in observational studies.

Fine PE, Williams TN, Aaby P, Källander K, Moulton LH, Flanagan KL, Smith PG, Benn CS; Working Group on Non-specific Effects of Vaccines.

Trop Med Int Health. 2009 Sep;14(9):969-76. doi: 10.1111/j.1365-3156.2009.02301.x. Epub 2009 Jun 15. Review.

40.

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.

Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, Blitz R, Mvula H, Newport MJ, Branson K, McGrath N, Crampin AC, Fine PE, Dockrell HM.

J Infect Dis. 2009 Mar 15;199(6):795-800.

41.

HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi.

Houben RM, Crampin AC, Mallard K, Mwaungulu JN, Yates MD, Mwaungulu FD, Ngwira BM, French N, Fine PE, Glynn JR.

Trans R Soc Trop Med Hyg. 2009 Dec;103(12):1187-9. doi: 10.1016/j.trstmh.2009.03.013. Epub 2009 Apr 11.

42.

What has Karonga taught us? Tuberculosis studied over three decades.

Crampin AC, Glynn JR, Fine PE.

Int J Tuberc Lung Dis. 2009 Feb;13(2):153-64.

43.

Leprosy's global statistics--still room for improvement.

Fine PE.

Lepr Rev. 2008 Sep;79(3):235-8. No abstract available.

PMID:
19009972
44.

Individual, household and community factors associated with HIV test refusal in rural Malawi.

Kranzer K, McGrath N, Saul J, Crampin AC, Jahn A, Malema S, Mulawa D, Fine PE, Zaba B, Glynn JR.

Trop Med Int Health. 2008 Nov;13(11):1341-50. doi: 10.1111/j.1365-3156.2008.02148.x. Epub 2008 Oct 6.

45.

Estimating the extent of vaccine-derived poliovirus infection.

Wringe A, Fine PE, Sutter RW, Kew OM.

PLoS One. 2008;3(10):e3433. doi: 10.1371/journal.pone.0003433. Epub 2008 Oct 29.

46.

Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus?

Ben-Smith A, Gorak-Stolinska P, Floyd S, Weir RE, Lalor MK, Mvula H, Crampin AC, Wallace D, Beverley PC, Fine PE, Dockrell HM.

BMC Infect Dis. 2008 Oct 15;8:139. doi: 10.1186/1471-2334-8-139.

47.

Implication of new WHO growth standards on identification of risk factors and estimated prevalence of malnutrition in rural Malawian infants.

Prost MA, Jahn A, Floyd S, Mvula H, Mwaiyeghele E, Mwinuka V, Mhango T, Crampin AC, McGrath N, Fine PE, Glynn JR.

PLoS One. 2008 Jul 16;3(7):e2684. doi: 10.1371/journal.pone.0002684.

48.

Determinants of cluster size in large, population-based molecular epidemiology study of tuberculosis, northern Malawi.

Glynn JR, Crampin AC, Traore H, Chaguluka S, Mwafulirwa DT, Alghamdi S, Ngwira BM, Yates MD, Drobniewski FD, Fine PE.

Emerg Infect Dis. 2008 Jul;14(7):1060-6. doi: 10.3201/eid1407.060468.

49.

Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi.

Glynn JR, Crampin AC, Ngwira BM, Ndhlovu R, Mwanyongo O, Fine PE.

Sex Transm Infect. 2008 Oct;84(5):356-60. doi: 10.1136/sti.2008.030056. Epub 2008 Jun 4.

50.

Use of antenatal clinic surveillance to assess the effect of sexual behavior on HIV prevalence in young women in Karonga district, Malawi.

Crampin AC, Jahn A, Kondowe M, Ngwira BM, Hemmings J, Glynn JR, Floyd S, Fine PE, Zaba B.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):196-202. doi: 10.1097/QAI.0b013e31817236c4.

Supplemental Content

Support Center